Latest News
Learn about a new concept for restoring sight to damaged eyes, how researchers are turning a patients’ own cells into retinal ganglion cells, a discussion regarding the medical vs. surgical treatment of glaucoma, and more in the summer edition of our glaucoma newsletter.
BrightFocus event recognizes top scientists and advocates in Alzheimer's and vision disease.
BrightFocus Foundation today honored five scientists in the fields of macular degeneration and glaucoma research, awarding them grants named in honor of leaders in vision research and advocacy.
Noted vision researcher Dr. Dean Bok of UCLA is the recipient of the prestigious 2016 Helen Keller Prize for Vision Research. Dr. Bok is being honored for more than four decades of discoveries in the field of retinal cell biology.
The spring 2016 edition of Alzheimer's Disease Research Review addresses the consequences of brain injury on Alzheimer’s disease, and the potential protective benefits of statins (cholesterol-lowering medications) in improving brain recovery after a concussion. Also read about BrightFocus Foundation's support of the Dementia Friendly America Campaign, meet Makoto Ishii, MD, PhD, who is investigating the complex interactions between body weight and Alzheimer’s disease, and much more.
BrightFocus Foundation today announced $11.7 million in promising new scientific research projects, its largest annual investment toward finding cures for Alzheimer’s disease, macular degeneration, and glaucoma.
CentraSight® by VisionCare Ophthalmic Technologies, Inc., today announced a partnership with leading non-profit, BrightFocus Foundation to further patient research and education for advanced age-related macular degeneration (AMD) through a direct-to-patient outreach and survey program.
The spring edition of our macular degeneration research newsletter explores new treatments that are on the horizon, what to expect when it comes to injections, and more.